BioRestorative Therapies to Participate at the RHK Capital Disruptive Growth Conference on Dec. 5-6, 2022
MELVILLE N.Y., Nov. 29, 2022 (GLOBE NEWSWIRE) — via InvestorWire – BioRestorative Therapies, Inc. (Nasdaq:BRTX) today announced that Lance Alstodt, its CEO, will be participating at the RHK Capital Disruptive Growth Conference in New York City.
Related news for (BRTX)
- BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025
- BioRestorative Therapies Reports 2024 Financial Results and Provides Business Update
- Today’s Top Performers: MoBot’s Market Review 02/25/25 07:00 PM
- MoBot’s Stock Market Highlights – 02/25/25 06:00 PM
- MoBot’s Stock Market Highlights – 02/20/25 08:00 AM
